http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0194548-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-14 |
| filingDate | 1986-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1988-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0194548-A3 |
| titleOfInvention | Sulfonylaminoethyl compounds, medicines containing these compounds and process for their preparation |
| abstract | The invention relates to new sulfonylaminoethyl compounds of the general formula in the R₁ is a phenyl group which is mono- or disubstituted by a methyl group or a halogen atom, where the substituents can be the same or different, an optionally substituted by a halogen atom, a biphenyl yl group, a naphthyl, pyridyl or thienyl group, R₂ is a hydrogen atom or a methyl group, A is a methylene or methyleneoxy group, the oxygen atom being linked to the adjacent radical B, B is a phenylene or naphthylene group and E is a hydroxycarbonyl or alkoxycarbonyl bonded via a straight-chain or branched alkylene or alkenylene group, a methylene group of the above-mentioned alkylene or alkenylene radicals, which must be linked to radical B, being replaced by a hydroxymethylene or carbonyl group, or mean a 4,5-dihydropyridazin-3-one-6-yl group optionally substituted in the carbon skeleton by 1 or 2 alkyl groups, and their salts with inorganic or organic bases if E contains a hydroxycarbonyl group.n n n The new compounds have valuable pharmacologicalnProperties, especially antithrombotic effects,nmoreover, these are thromboxane antagonists, and readnsen to produce according to known methods. |
| priorityDate | 1985-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.